Jingjing Sun

Jingjing Sun

Jingjing is an accomplished life sciences leader with a strong biotechnology background and venture capital experience at TVM Capital. She brings deep expertise in business development across biotech and pharma, with a particular focus on cross-border innovation and...
Aurélien Chollet

Aurélien Chollet

Aurélien holds a PhD in Chemistry/Health Care (Paul Sabatier University) and a master’s degree in management of pharmaceutical industries (Toulouse Business School). Aurélien joined Antabio in 2015. As Vice-President Finance & Operations, Aurélien’s...
Magdalena Zalacain

Magdalena Zalacain

Magda has over 20 years’ experience in antibacterial drug discovery in the pharmaceutical industry (GSK) with proven ability to progress antibacterial efforts from target identification to clinical trials. While at GSK, she led the microbiology group with...
Gordon Waldron

Gordon Waldron

Gordon has over 25 years’ experience in high tech, med tech and biotech. During his career, he has raised over €200M in venture capital funding, over €50M in an IPO and has been involved in 10 M&A / Exit transactions. Gordon is the Former Vice President and Chief...
Rienk Pypstra

Rienk Pypstra

Rienk is a pharmaceutical physician with three decades of experience in infectious disease global drug development, with a focus on drug development strategy and operational excellence. Rienk has held leadership roles in clinical pharmacology, early and late...